Bloodstream infections in cancer patients

European Journal of Cancer

Volumn 41, Issue 10, 2005, Pages 1370-1371

  Hughes, Walter T ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; COTRIMOXAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC PROPHYLAXIS; BLOOD FLOW; CANCER PATIENT; CLINICAL TRIAL; DRUG SAFETY; EDITORIAL; ESCHERICHIA COLI; FEBRILE NEUTROPENIA; GRAM NEGATIVE SEPSIS; HUMAN; INFECTION PREVENTION; LEUKEMIA; NONHUMAN; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BACTEREMIA; CHILD; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASMS;

EID: 20444471439     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.04.004     Document Type: Editorial

References (6)

1. Castagnola E, Caviglia I, Pistorio A, et al. Bloodstream infections and invasive mycoses in children undergoing treatment for acute leukaemia: a 13-year experience at a single institution. Eur J Cancer 2005 (current issue).
2. J.L. Robinson, and R.P. Rennie Outcome of bacteremia and fungemia in paediatric oncology patients Can J Infect Dis Microbiol 13 2002 375 381
3. J.W. Gray A 7-year study of bloodstream infections in an English children's hospital Eur J Pediatr 163 2004 530 535
4. van de Wetering MD, de Witte MA, Kremer LCM, et al. Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomized controlled trials. Eur J Cancer. 2005 (current issue).
5. Kern WV, Klose K, Jellen-Ritter AS, et al. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukaemia. Eur J Clin Microbiol Infect Dis. 2005; Feb 16 [Epub ahead of print].
6. W.T. Hughes, S. Kuhn, and S. Chaudhary Successful chemoprophylaxis for Pneumocystis carinii pneumonitis New Engl J Med 297 1977 1419 1426